These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 1712247

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Mechanism of resistance to cyclopentenyl cytosine (CPE-C) in Molt-4 lymphoblasts.
    Blaney SM, Grem JL, Balis FM, Cole DE, Adamson PC, Poplack DG.
    Biochem Pharmacol; 1993 Apr 06; 45(7):1493-501. PubMed ID: 8471071
    [Abstract] [Full Text] [Related]

  • 5. Studies on the antitumor activity and biochemical actions of cyclopentenyl cytosine against human colon carcinoma HT-29 in vitro and in vivo.
    Gharehbaghi K, Zhen W, Fritzer-Szekeres M, Szekeres T, Jayaram HN.
    Life Sci; 1999 Apr 06; 64(2):103-12. PubMed ID: 10069488
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Antiproliferative effects of cyclopentenyl cytosine (NSC 375575) in human glioblastoma cells.
    Agbaria R, Kelley JA, Jackman J, Viola JJ, Ram Z, Oldfield E, Johns DG.
    Oncol Res; 1997 Apr 06; 9(3):111-8. PubMed ID: 9220496
    [Abstract] [Full Text] [Related]

  • 8. Cyclopentenyl cytosine induces apoptosis and increases cytarabine-induced apoptosis in a T-lymphoblastic leukemic cell-line.
    Verschuur AC, Brinkman J, Van Gennip AH, Leen R, Vet RJ, Evers LM, Voûte PA, Van Kuilenburg AB.
    Leuk Res; 2001 Oct 06; 25(10):891-900. PubMed ID: 11532523
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cyclopentenyl cytosine primes SK-N-BE(2)c neuroblastoma cells for cytarabine toxicity.
    Bierau J, Van Gennip AH, Leen R, Helleman J, Caron HN, Van Kuilenburg AB.
    Int J Cancer; 2003 Jan 20; 103(3):387-92. PubMed ID: 12471622
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Cyclopentenyl cytosine (CPEC): an overview of its in vitro and in vivo activity.
    Schimmel KJ, Gelderblom H, Guchelaar HJ.
    Curr Cancer Drug Targets; 2007 Aug 20; 7(5):504-9. PubMed ID: 17691910
    [Abstract] [Full Text] [Related]

  • 19. Cyclopentenyl cytosine inhibits cytidine triphosphate synthetase in paediatric acute non-lymphocytic leukaemia: a promising target for chemotherapy.
    Verschuur AC, Van Gennip AH, Leen R, Muller EJ, Elzinga L, Voûte PA, Van Kuilenburg AB.
    Eur J Cancer; 2000 Mar 20; 36(5):627-35. PubMed ID: 10738128
    [Abstract] [Full Text] [Related]

  • 20. Cyclopentenylcytosine triphosphate. Formation and inhibition of CTP synthetase.
    Kang GJ, Cooney DA, Moyer JD, Kelley JA, Kim HY, Marquez VE, Johns DG.
    J Biol Chem; 1989 Jan 15; 264(2):713-8. PubMed ID: 2910861
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.